Xiaohui Wang

Xiaohui Wang

Auto-generated profile, based on publicly available information

Xiaohui Wang

Department of Nuclear Medicine, The first Hospital of Lanzhou University, Lanzhou, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2024 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
XWXiaohui Wang
Xiaohui Wang
ZHZhijian Han
Zhijian Han
JZJun ZHANG
Jun ZHANG
MCMing Chen
Ming Chen
WMWenbo Meng
Wenbo Meng

10 February 2025 in Molecular Pharmaceutics
Verified
Journal Article
Open access
XWXiaohui Wang
Xiaohui Wang
CZCaiyu Zhuang
Caiyu Zhuang
XZXinhui Zheng
Xinhui Zheng
XZXiaolei Zhang
Xiaolei Zhang
ZHzhijian Han
zhijian Han
RWRenhua Wu
Renhua Wu
Cancer-associated fibroblasts (CAFs) are essential components of the tumor microenvironment. Fibroblast activation protein (FAP) is overexpressed in CAFs. FAP-targeted molecular imaging agents, including the FAP inhibitors (FAPIs), have shown promising results in tumor diagnosis. We aimed to design a Gd-labeled FAPI Dimer, Gd-DOTA-Suc-Lys-(FAPI04)2, to optimize the pharmacokinetics and evaluate its potential capacity for targeting FAP-positive solid tumors in vivo. The Gd-labeled FAPI Dimer was successfully synthesized with exceeding 98% purity. Preclinical pharmacokinetics were determined in assessed FAP-positive U87 cell-derived xenografts and FAP-negative C6-derived xenografts using small-animal T1-weighted 7.0T MR imaging. The longitudinal correlation coefficient (r1) of the agent was 3.813 mM-1·S-1. The administration of the Gd-FAPI04 Dimer probe showed a notable enhancement of tumor contrast on T1-weighted whole-body MRI. At 10 and 30 minutes post-injection, the U87 subcutaneous tumor demonstrated significantly greater contrast enhancement than the C6 subcutaneous tumor (P <0.05). In vivo, the safety of the Gd-FAPI-04 Dimer probe was evaluated, which showed no tissue damage in vital organs like the heart, liver, spleen, lung, and kidneys, as indicated by unchanged morphology compared to a normal saline control group. The novel Gd-FAPI04 Dimer molecular probe, Gd-DOTA-Suc-Lys-(FAPI-04)2 specifically targeting FAP may serve as a safe and promising tool for the diagnostic imaging of solid tumors.

9 May 2025 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
ZLZhijun Li
Zhijun Li
TPTukang Peng
Tukang Peng
MYMin Yang
Min Yang
YQYifan Qiu
Yifan Qiu
PYPeizhen Ye
Peizhen Ye
HJHongjun Jin
Hongjun Jin

1 July 2025 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
XWXiaohui Wang
Xiaohui Wang
QLQiwen Li
Qiwen Li
PYPeng Yang
Peng Yang
ZPZhenzhen Peng
Zhenzhen Peng
CWChunyan Wang
Chunyan Wang
MCMing Chen
Ming Chen
Bone scintigraphy and SPECT/CT imaging characteristics in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome